James C. Anderson, and Anderson Podiatry Center, P.C. v. Biegler GmbH, and Solace Advancement, LLC

District Court, D. Colorado·Decided September 11, 2026·No. 1:24-cv-01603·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLORADO Judge Nina Y. Wang

Civil Action No. 24-cv-01603-NYW-SBP

JAMES C. ANDERSON, and ANDERSON PODIATRY CENTER, P.C.,

Plaintiffs,

v.

BIEGLER GMBH, and SOLACE ADVANCEMENT, LLC

Defendants.

ORDER ON MOTION TO DISMISS

This matter is before the Court on the Defendant Biegler GmbH’s Motion to Dismiss Plaintiffs’ Amended Complaint (the “Motion” or “Motion to Dismiss”). [Doc. 80]. For the reasons set forth below, the Motion to Dismiss is respectfully GRANTED. BACKGROUND1 Plaintiff James C. Anderson (“Dr. Anderson”) is a physician practicing in Fort Collins, Colorado at Anderson Podiatry Center, P.C. [Doc. 71 at ¶¶ 33–34]. Defendant Biegler GmbH (“Defendant” or “Biegler”) is an Austrian corporation with its principal place of business in Austria. [Id. at ¶ 36]. Plaintiffs allege that Biegler “was engaged in the manufacturing, sale, distribution

1 The Court takes the following well-pleaded factual allegations from the First Amended Complaint and Demand for Jury Trial (the “Amended Complaint”), [Doc. 71], and accepts them as true for purposes of the Motion to Dismiss, see XMission, L.C. v. Fluent LLC, 955 F.3d 833, 836 (10th Cir. 2020). and marketing” of a medical device called the “Stivax System,” also referenced as the “Stivax device.” [Id. at ¶¶ 2, 36]. The Stivax device is “a single use, battery-powered, electrical nerve stimulator which is used for the stimulation of the vagus nerve via the ear.” [Id. at ¶ 3 (quotation omitted)]. Plaintiffs allege that Biegler and co-Defendant

Solace Advancement, LLC (“Solace”) erroneously promoted the Stivax device as an implantable non-narcotic pain management medical device that was reimbursable under certain Medicare codes. [Id. at ¶¶ 8–9]. According to Plaintiffs, “Defendants, their agents[,] and subagents instructed Dr. Anderson and Anderson Podiatry how to bill Medicare and other government healthcare payors for the Stivax device using codes that Defendants, their agents[,] and subagents . . . knew to be improper for the Stivax device.” [Id. at ¶ 11]. Specifically, Plaintiffs allege, upon information and belief, that Defendants engaged with a number of other non-parties to create the “Stivax System Enterprise”: Biegler manufactured the device; Solace . . . imported and contracted with [non-party] Doc Solutions, its agent NexMed and NexMed’s subagent Nightingale [International, LLC] to distribute the Stivax device utilizing the U.S. Postal Service and/or private and/or commercial interstate carriers; [non-party] NexMed fulfilled orders submitted by medical providers; and [non-parties] [Jack] Haga, Nightingale, [John C.] Dawkins and [A. Scott] Burgess utilized the U.S. Mail, private and/or commercial interstate carriers and emails transmitted by wire to continuously misrepresent the Stivax device through fraudulent misrepresentations during internet and/or in person presentations, training, education, and instructions to Plaintiffs and the named healthcare providers in California and other States in the U.S.A.

[Id. at ¶ 91]. Plaintiffs “purchased more than one hundred Stivax devices from the Stivax System Enterprise” and submitted claims for reimbursement to Medicare “using Stivax System Enterprise recommended [billing] codes” for implantable devices. [Id. at ¶¶ 91, 95]. “Medicare claim[ed] at least $276,162.26 in overpayments made under” the erroneous codes. [Id. at ¶ 95]. Plaintiffs initiated this action on June 7, 2024. See [Doc. 1]. In August 2025, the Court granted Biegler’s motion to dismiss Plaintiffs’ claims for lack of personal jurisdiction. See [Doc. 63].2 Thereafter, Plaintiffs filed an unopposed motion to amend their complaint,

see [Doc. 66], which the Court granted, see [Doc. 70]. Plaintiffs filed the operative Amended Complaint on October 9, 2025. [Doc. 71]. They assert six claims, each against both Defendants: (1) a civil claim under the Racketeer Influenced and Corrupt Organizations Act (“RICO”), 18 U.S.C. § 1964(c) (“Claim One”), [Doc. 71 at ¶¶ 126–36]; (2) a civil RICO conspiracy claim (“Claim Two”), [id. at ¶¶ 137–43]; (3) a fraudulent misrepresentation claim (“Claim Three”), [id. at ¶¶ 144–50]; (4) a fraudulent concealment claim (“Claim Four”), [id. at ¶¶ 151–56]; (5) a common law civil conspiracy claim (“Claim Five”), [id. at ¶¶ 157–61]; and (6) a claim under the Colorado Consumer Protection Act (“CCPA”) (“Claim Six”), [id. at ¶¶ 162–73]. Biegler moves to dismiss Plaintiffs’ claims for lack of personal jurisdiction, or alternatively, for failure to state a claim. [Doc. 80].

LEGAL STANDARDS I. Personal Jurisdiction Personal jurisdiction is “an essential element of the jurisdiction of a district court,” and without it, “the court is ‘powerless to proceed to an adjudication.’” Ruhrgas AG v. Marathon Oil Co., 526 U.S. 574, 584 (1999) (quoting Emps. Reinsurance Corp. v. Bryant,

2 The Supreme Court’s decision in Fuld v. Palestine Liberation Organization, 606 U.S. 1 (2025), which is discussed in detail below, was issued a few weeks before this Court’s ruling on Biegler’s first motion to dismiss. The Parties’ briefing on that motion was complete before the Fuld was decided, so the Parties did not discuss that case in their personal jurisdiction arguments, see [Doc. 34; Doc. 58; Doc. 59], but they do raise arguments about Fuld’s applicability in their instant briefing, see [Doc. 80; Doc. 82]. 299 U.S. 374, 382 (1937)). The plaintiff bears the burden of demonstrating a court’s personal jurisdiction over a defendant. Melea, Ltd. v. Jawer SA, 511 F.3d 1060, 1065 (10th Cir. 2007).3 Relevant here, Rule 4(k)(2) of the Federal Rules of Civil Procedures “serves as a

federal long-arm statute, which allows a district court to exercise personal jurisdiction over a foreign defendant whose contacts with the United States, but not with the forum state, satisfy due process.” Synthes (U.S.A.) v. G.M. Dos Reis Jr. Ind. Com de Equip. Medico, 563 F.3d 1285, 1296 (Fed. Cir. 2009). The rule provides that [f]or a claim that arises under federal law, serving a summons or filing a waiver of service establishes personal jurisdiction over a defendant if (A) the defendant is not subject to jurisdiction in any state’s courts of general jurisdiction; and (B) exercising jurisdiction over the defendant would be consistent with the United States Constitution and laws.

Fed. R. Civ. P. 4(k)(2). In other words, a court may exercise personal jurisdiction over a foreign defendant under Rule 4(k)(2) if three requirements are met: “(1) the plaintiff’s claim arises under federal law; (2) the defendant is not subject to jurisdiction in any state’s courts of general jurisdiction; and (3) the exercise of jurisdiction comports with due process.” Pandaw Am., Inc. v. Pandaw Cruises India Pvt. Ltd., 842 F. Supp. 2d 1303, 1310 (D. Colo. 2012). Personal jurisdiction under Rule 4(k)(2) must comply with the “constitutional limitations imposed by the Fifth Amendment’s Due Process Clause, rather

Free access — add to your briefcase to read the full text and ask questions with AI

James C. Anderson, and Anderson Podiatry Center, P.C. v. Biegler GmbH, and Solace Advancement, LLC, (D. Colo. 2026).

James C. Anderson, and Anderson Podiatry Center, P.C. v. Biegler GmbH, and Solace Advancement, LLC (James C. Anderson, and Anderson Podiatry Center, P.C. v. Biegler GmbH, and Solace Advancement, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Employers Reinsurance Corp. v. Bryant
299 U.S. 374 (Supreme Court, 1937)
International Shoe Co. v. Washington
326 U.S. 310 (Supreme Court, 1945)
World-Wide Volkswagen Corp. v. Woodson
444 U.S. 286 (Supreme Court, 1980)
Burger King Corp. v. Rudzewicz
471 U.S. 462 (Supreme Court, 1985)
Ruhrgas Ag v. Marathon Oil Co.
526 U.S. 574 (Supreme Court, 1999)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Adler v. Wal-Mart Stores, Inc.
144 F.3d 664 (Tenth Circuit, 1998)
Peay v. BellSouth Medical Assistance Plan
205 F.3d 1206 (Tenth Circuit, 2000)
Issa v. Comp USA
354 F.3d 1174 (Tenth Circuit, 2003)
Garrett v. Selby Connor Maddux & Janer
425 F.3d 836 (Tenth Circuit, 2005)
Brereton v. Bountiful City Corp.
434 F.3d 1213 (Tenth Circuit, 2006)
Tal v. Hogan
453 F.3d 1244 (Tenth Circuit, 2006)
Mann v. Boatright
477 F.3d 1140 (Tenth Circuit, 2007)
Melea, Ltd. v. Jawer Sa
511 F.3d 1060 (Tenth Circuit, 2007)
Dudnikov v. Chalk & Vermilion Fine Arts, Inc.
514 F.3d 1063 (Tenth Circuit, 2008)
Dalton v. City of Las Vegas
282 F. App'x 652 (Tenth Circuit, 2008)
Cordova v. Aragon
569 F.3d 1183 (Tenth Circuit, 2009)